By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has signed a collaboration with Affymetrix to develop RNA Control Kits for molecular diagnostic applications.

Under the agreement, Asuragen will develop and manufacture the kits, which are intended for use with in vitro transcription reagent kits for clinical molecular diagnostic applications, for Affymetrix. The Austin, Texas-based firm said that the kits will enable Affy to supply its molecular diagnostic partners with complete solutions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene regulation changes linked to human brain evolution, and more.

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.